首页> 外文会议>International conference on public administration >The Policy Choices for Developing Modern Biotechnology Industry in China
【24h】

The Policy Choices for Developing Modern Biotechnology Industry in China

机译:中国发展现代生物技术产业的政策选择

获取原文

摘要

In the decades, biotechnology industry developed quickly, especially in North America, European Union, and Japan. China also selected modern biotechnology industry as the strategic emerging industry. Modern biotechnology management research emerged and prospered in China recently. One of the most important research fields of modern biotechnology is industry innovation and industry policy. This paper described the development of biotechnology industry based on the literature review, generalized the characteristics of biological pharmaceutical which is the typical representation of biotechnology industry. Then, this paper analyzed the prominent contradictions of biotechnology industry in China, (1) Conflict between resource shortage and strategic industry selection, (2) Contradiction between catching-up and progressive development; (3) Conflict between growth opportunity and challenge; (4) Conflict between supernormal development and coordinated progress; (6) Conflict between big group strategy and small business innovation strategy. Based on the upper analysis, this paper studied possible policy choices for the government to develop biotechnology industry, including (1) Accelerate the formulation of national biotechnology industry development strategy; (2) Fully exert government's function at organization and coordination; (3) Energetically promote biological technology innovation system construction; (4) Adhere to the guidelines of "do some things, and leave some things undone"; and (5) Raise biotechnology industry scale economic level.
机译:几十年来,生物技术产业发展迅速,特别是在北美,欧盟和日本。中国还选择了现代生物技术产业作为战略性新兴产业。最近,现代生物技术管理研究在中国兴起并蓬勃发展。现代生物技术最重要的研究领域之一是产业创新和产业政策。本文在文献综述的基础上描述了生物技术产业的发展,概括了生物制药的特征,这是生物技术产业的典型代表。然后,本文分析了中国生物技术产业的突出矛盾:(1)资源短缺与战略性产业选择之间的冲突;(2)追赶与渐进式发展之间的矛盾; (3)增长机会与挑战之间的冲突; (四)超常发展与协调进步之间的矛盾; (6)大集团战略与小企业创新战略之间的冲突。在以上分析的基础上,本文研究了政府发展生物技术产业的可能政策选择,包括:(1)加快制定国家生物技术产业发展战略; (二)充分发挥政府的组织协调作用; (三)大力推进生物技术创新体系建设; (四)坚持“办事不做”的方针; (五)提高生物技术产业规模经济水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号